UNLABELLED: Anxiety is a dynamic response to perceived threat that is common among patients with cancer and fluctuates at critical points in the disease trajectory. A substantial minority of patients may experience clinically significant anxiety resulting from a range of potential etiologic factors. This review summarizes evidence-based recommendations for treatment of anxiety in oncology settings. Recommendations are based on the nature and time course of anxiety and the results of meta-analyses, systematic reviews, and individual trials in cancer populations. The evidence-based literature supports the use of psychosocial and psychopharmacologic treatments to prevent or alleviate anxiety symptoms. CONCLUSIONS: are tempered by study heterogeneity and methodologic limitations and a lack of trials that included patients with clinically significant anxiety. In oncology settings, accessibility and acceptability of evidence-based treatments vary, and patients may seek a variety of resources to manage cancer concerns. Treatment planning should incorporate contributing factors to anxiety and patient preferences for psychiatric care.
UNLABELLED: Anxiety is a dynamic response to perceived threat that is common among patients with cancer and fluctuates at critical points in the disease trajectory. A substantial minority of patients may experience clinically significant anxiety resulting from a range of potential etiologic factors. This review summarizes evidence-based recommendations for treatment of anxiety in oncology settings. Recommendations are based on the nature and time course of anxiety and the results of meta-analyses, systematic reviews, and individual trials in cancer populations. The evidence-based literature supports the use of psychosocial and psychopharmacologic treatments to prevent or alleviate anxiety symptoms. CONCLUSIONS: are tempered by study heterogeneity and methodologic limitations and a lack of trials that included patients with clinically significant anxiety. In oncology settings, accessibility and acceptability of evidence-based treatments vary, and patients may seek a variety of resources to manage cancer concerns. Treatment planning should incorporate contributing factors to anxiety and patient preferences for psychiatric care.
Authors: Thomas J Herzog; Deborah K Armstrong; Mark F Brady; Robert L Coleman; Mark H Einstein; Bradley J Monk; Robert S Mannel; J Tate Thigpen; Sharee A Umpierre; Jeannine A Villella; Ronald D Alvarez Journal: Gynecol Oncol Date: 2013-11-15 Impact factor: 5.482
Authors: Devesh Oberoi; Victoria M White; John F Seymour; H Miles Prince; Simon Harrison; Michael Jefford; Ingrid Winship; David Hill; Damien Bolton; Anne Kay; Jeremy Millar; Nicole Wong Doo; Graham Giles Journal: Support Care Cancer Date: 2017-06-30 Impact factor: 3.603
Authors: Alix E Hall; Rob W Sanson-Fisher; Mariko L Carey; Chris Paul; Anna Williamson; Ken Bradstock; H Sharon Campbell Journal: Support Care Cancer Date: 2016-05-31 Impact factor: 3.603
Authors: Jamie M Jacobs; Kelly M Shaffer; Ryan D Nipp; Joel N Fishbein; James MacDonald; Areej El-Jawahri; William F Pirl; Vicki A Jackson; Elyse R Park; Jennifer S Temel; Joseph A Greer Journal: Ann Behav Med Date: 2017-08
Authors: Kemi M Doll; Emma L Barber; Jeannette T Bensen; Matthew C Revilla; Anna C Snavely; Antonia V Bennett; Bryce B Reeve; Paola A Gehrig Journal: Am J Obstet Gynecol Date: 2016-04-27 Impact factor: 8.661